Megan Klatt, PharmD, BCIDP (she/her/hers)

Infectious Diseases/Antimicrobial Stewardship Pharmacist
The University of Kansas Health System, KS, United States

Megan Klatt, PharmD, BCIDP, DPLA is an Infectious Diseases and Antimicrobial Stewardship Clinical Pharmacist at The University of Kansas Health System in Kansas City, Kansas. She received her PharmD from the University of Michigan College of Pharmacy and completed her PGY1 Pharmacy residency at the University of Wisconsin Health, and her PGY2 Infectious Diseases residency at Michigan Medicine. Her practice and research interests include inpatient and ambulatory antimicrobial stewardship, gram-negative resistance, and antimicrobial pharmacokinetics/pharmacodynamics.

Disclosure(s): No financial relationships to disclose

Presentation(s):

• 311 - Defining the magnitude of desirability of outcome ranking (DOOR) differences in effectiveness of Ceftazidime-Avibactam (CZA) versus Ceftolozane-Tazobactam (C/T) for multidrug-resistant (MDR) Pseudomonas aeruginosa infections in the United States (CACTUS)

  Friday, October 18, 2024
  10:42 AM – 10:54 AM US PT

• 312 - Impact of Patient Subgroups on the Efficacy of Ceftazidime-Avibactam (CZA) versus Ceftolozane-Tazobactam (C/T) for Multidrug-resistant (MDR) Pseudomonas aeruginosa infections in the United States (CACTUS)

  Friday, October 18, 2024
  10:54 AM – 11:06 AM US PT